EP Biocomposites Ltd (EPBIO) — shareholding pattern, promoter holding, financials and share price
About EP Biocomposites Ltd (EPBIO)
EP Biocomposites Ltd operates in the Waste Management industry, within the Utilities sector. It trades on the NSE as EPBIO and on the BSE under scrip code 543595. Its ISIN is INE0D2I01014.
Incorporated in 2020, EP Biocomposites Ltd manufactures fibre reinforced polymer products and provides bio toilet solutions [1]
EP Biocomposites Limited specializes in manufacturing fibre reinforced polymer products and bio-toilet solutions aimed at promoting sustainability.
The company has installed over 2 lakh FRP doors, contributing significantly to tree conservation.
Listed peers in Waste Management: Eco Recycling Ltd, Concord Enviro Systems Ltd, VVIP Infratech Ltd, Organic Recycling Systems Ltd, Race Eco Chain Ltd, Gem Enviro Management Ltd.
Valuation & Returns
10 Jul 2026At ₹99.91 a share on 10 Jul 2026, EP Biocomposites Ltd (EPBIO) was valued at a price-to-earnings ratio of 11.52x against an industry P/E of 28.25x and a price-to-book of 1.39x on a book value of ₹71.67 per share. Solomo computes return on equity of 12.1% and return on capital employed of 15.76% from filed results.
- P/E
- 11.52x
- Industry P/E
- 28.25x
- P/B
- 1.39x
- EPS (TTM)
- ₹8.67
- Book value / share
- ₹71.67
- ROE
- 12.1%
- ROCE
- 15.76%
- ROA
- 7.79%
- Debt / equity
- 0.2x
- Dividend yield
- 0%
- EBITDA margin
- 17.45%
- 52-week range
- ₹75.5 – ₹149.9
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, EP Biocomposites Ltd (EPBIO) reported revenue of ₹13.64 crore, net profit of ₹1.46 crore and earnings per share of ₹8.68. That compares with revenue of ₹12.01 crore and net profit of ₹1.03 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹9.57 crore and net profit ₹1.37 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 8.06 | 7.12 | 11.43 | 12.01 | 13.64 |
| Net profit (₹ cr) | 0.81 | 0.58 | 1.15 | 1.03 | 1.46 |
| EPS (₹) | 6.88 | 3.45 | 6.84 | 6.13 | 8.68 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 84.08% | 14.21% | 4.98% |
| Profit growth | 100.77% | 8.39% | -10.43% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 70.08% of EP Biocomposites Ltd (EPBIO) (unchanged from the previous quarter). Market capitalisation was ₹17 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2022.
Largest disclosed public shareholders in Mar 2026: KAVITA KUMAR SANTOSH 2.08%, SAMBHAV DAWAR 1.61%, RAJIV MEHTA 1.31%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 70.08% | - | - | - | 29.92% |
| Dec 2025 | 70.08% | - | - | - | 29.92% |
| Sep 2025 | 70.05% | - | - | - | 29.95% |
| Jun 2025 | 70.08% | - | - | - | 29.92% |
| Mar 2025 | 70.08% | - | - | - | 29.92% |
| Dec 2024 | 70.08% | - | - | - | 29.92% |
| Sep 2024 | 70.08% | - | - | - | 29.92% |
| Jun 2024 | 70.08% | - | - | - | 29.92% |